跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,580 条关于
“KV7 potassium channel”
全部
8,580
临床试验
7,400
药物
416
机构
27
资讯
737
9个月前
Xenon Pharmaceuticals to Present Long-Term Azetukalner Data at AES 2025, Highlighting Extended Seizure Freedom
去年
Xenon Pharmaceuticals Appoints Darren Cline as Chief Commercial Officer Ahead of Azetukalner Phase 3 Data
8个月前
Adolore BioTherapeutics Receives FDA Orphan Drug Designation for Gene Therapy Targeting Erythromelalgia
去年
Xenon Pharmaceuticals Advances Azetukalner Program for Epilepsy and MDD
23天前
SK Biopharm licenses Biohaven's Kv7 activator Opakalim in $795M deal, targeting 2029 US launch
去年
Adolore BioTherapeutics Reports Positive Preclinical Data for Gene Therapy Targeting Chronic Knee Pain
去年
QurAlis Reports Promising Phase 1 Data for QRL-101 in ALS and Epilepsy Biomarker Study
23小时前
Xenon Submits Azetukalner NDA to FDA for Focal Seizures, Pauses Psychiatry Enrollment on Neuropsychiatric Events
8天前
FDA Partial Clinical Hold Halts New Enrollment in SK Biopharmaceuticals' Opacalim RISE2 Epilepsy Trial
去年
QurAlis Expands Kv7 Program with QRL-101 into Epilepsy Treatment
第 1 页,共 74 页
上一页
下一页